| Q34307478 | A new function of human HtrA2 as an amyloid-beta oligomerization inhibitor |
| Q31041418 | A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling |
| Q48742654 | Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease |
| Q37028176 | Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils |
| Q37230015 | Amyloid beta protein: Abeta40 inhibits Abeta42 oligomerization |
| Q39420600 | Amyloid precursor protein and tau transgenic models of Alzheimer‘s disease: insights from the past and directions for the future |
| Q54959267 | Amyloid β-peptides 1-40 and 1-42 form oligomers with mixed β-sheets. |
| Q37364324 | Amyloid-beta peptide Abetap3-42 affects early aggregation of full-length Abeta1-42. |
| Q37106932 | An update on the toxicity of Abeta in Alzheimer's disease |
| Q37196122 | Animal models of Alzheimer's disease and frontotemporal dementia |
| Q37191689 | Aβ monomers transiently sample oligomer and fibril-like configurations: ensemble characterization using a combined MD/NMR approach |
| Q36827322 | Aβ40 has a subtle effect on Aβ42 protofibril formation, but to a lesser degree than Aβ42 concentration, in Aβ42/Aβ40 mixtures |
| Q37057927 | Basic pathologies of neurodegenerative dementias and their relevance for state-of-the-art molecular imaging studies |
| Q38589816 | Beta Amyloid Hallmarks: From Intrinsically Disordered Proteins to Alzheimer's Disease |
| Q42040291 | Bifunctional compounds for controlling metal-mediated aggregation of the aβ42 peptide |
| Q40785358 | C-Terminal Threonine Reduces Aβ43 Amyloidogenicity Compared with Aβ42. |
| Q27665898 | Converting the Highly Amyloidogenic Human Calcitonin into a Powerful Fibril Inhibitor by Three-dimensional Structure Homology with a Non-amyloidogenic Analogue |
| Q44369500 | Cross-seeding between Aβ40 and Aβ42 in Alzheimer's disease |
| Q38101383 | Development and mechanism of γ-secretase modulators for Alzheimer's disease |
| Q37381344 | Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery |
| Q47665801 | Disruption of amyloid precursor protein ubiquitination selectively increases amyloid β (Aβ) 40 levels via presenilin 2-mediated cleavage |
| Q37150728 | E22Q-mutant Abeta peptide (AbetaDutch) increases vascular but reduces parenchymal Abeta deposition |
| Q24633896 | Expression and purification of 15N- and 13C-isotope labeled 40-residue human Alzheimer's β-amyloid peptide for NMR-based structural analysis |
| Q24318268 | Interaction between soluble Aβ-(1-40) monomer and Aβ-(1-42) fibrils probed by paramagnetic relaxation enhancement |
| Q38230384 | Interpreting Alzheimer's disease clinical trials in light of the effects on amyloid-β. |
| Q34043216 | Kinetics of amyloid beta monomer-to-oligomer exchange by NMR relaxation. |
| Q35235869 | Modes of Aβ toxicity in Alzheimer's disease |
| Q46830566 | Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome. |
| Q37174236 | Neuronal protein trafficking associated with Alzheimer disease: from APP and BACE1 to glutamate receptors |
| Q24298670 | Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio |
| Q37157432 | Pulsed hydrogen-deuterium exchange mass spectrometry probes conformational changes in amyloid beta (Aβ) peptide aggregation |
| Q24671058 | Residual structure, backbone dynamics, and interactions within the synuclein family |
| Q39982408 | Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity |
| Q34402886 | Specific aromatic foldamers potently inhibit spontaneous and seeded Aβ42 and Aβ43 fibril assembly |
| Q35774046 | Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease |
| Q35061472 | Synergistic interactions between Alzheimer's Aβ40 and Aβ42 on the surface of primary neurons revealed by single molecule microscopy |
| Q47110086 | The Aβ40 and Aβ42 peptides self-assemble into separate homomolecular fibrils in binary mixtures but cross-react during primary nucleation. |
| Q24294387 | The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway |
| Q39101514 | The effect of Cu(2+) and Zn(2+) on the Aβ42 peptide aggregation and cellular toxicity |
| Q39951771 | The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity |
| Q26827421 | Transient dynamics of Aβ contribute to toxicity in Alzheimer's disease |
| Q36022784 | Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices? |
| Q91581374 | γ-Secretase and its modulators: Twenty years and beyond |
| Q39545955 | γ-Secretase complexes containing caspase-cleaved presenilin-1 increase intracellular Aβ(42) /Aβ(40) ratio |